查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1252566

全球数位治疗市场-按组件（软件、设备）、应用（糖尿病、肥胖、心血管、心理/行为健康、高血压、失眠）、销售渠道（B2B、B2C）、地区-预测到 2032 年

Digital Therapeutics Market - By Component (Software, Device), By Application (Diabetes, Obesity, Cardiovascular, Mental & Behavioural Health, Hypertension, Insomnia), By Sales Channel (B2B, B2C), By Region - Global Forecast to 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 169 Pages | 商品交期: 2-3个工作天内

价格

由于数位疗法在医疗保健领域的迅速采用以及提供更优质护理的潜力，预计到 2032 年全球数位疗法市场将稳步扩大。

此外，随着数位治疗解决方案成为医疗保健服务的重要组成部分，预计市场收入将显着增加。 技术进步、企业对研究的大量投资以及全球政府鼓励治疗慢性病的运动也促成了这种扩张。

例如，Teladoc Health 于 2022 年 2 月推出了慢性病管理系统 Chronic Care Complete。 该系统通过利用连接的健康监测系统并提供广泛的治疗计划，扩大了对健康教练、医生和心理健康专家的访问。 这一战略发布还使公司能够领先于竞争对手并增加收入。

数位治疗市场按组件、应用、销售渠道和区域进行细分。

在组件方面，推断设备细分市场将在预测期内获得显着的市场份额。 数位治疗设备因其在慢性病管理中的重要作用而获得认可，这是这一显着细分市场扩张的主要因素。 数位血糖仪会立即显示您的血糖是否在范围内。 凭藉蓝牙功能、同步移动应用程序和小巧纤薄的设计，客户可以就他们的健康做出更明智的决定，并开启新的预防可能性。

从应用来看，从 2023 年到 2032 年，心理和行为健康领域预计将以超过 34% 的复合年增长率增长。 这种快速增长归因于大量精神疾病患者以及在行为和心理健康治疗方面的高研发支出。 未满足的医疗需求和大流行病防范带来的压力推动了对心理健康解决方案的需求。

按地区划分，预计欧洲数位疗法市场在研究期间将稳步增长。 该地区的市场发展受到以下因素的推动：获得数位疗法的机会增加、建立单独的监管框架以适应 DTx 等尖端疗法、政府支持措施、利用率提高和数位疗法。它受到以下因素的推动：天使投资人涌入，投资于科技领域的高科技初创企业。

数位治疗市场的竞争格局相当成熟。 该行业的主要竞争对手包括 Virta Health Corp.、Omada Health、Akili Interactive Labs、Biofourmis, Inc.、Lark Health 等。

内容

第 1 章研究方法和范围

第 2 章执行摘要

第 3 章数位治疗行业洞察

  • 按行业细分
  • 2018-2032 年行业格局
  • 影响行业的因素
    • 司机
      • 慢性病增加
      • 越来越需要成本控制
      • 提高护理质量的可能性
      • 数位疗法的传播仍在继续
    • 行业潜在的风险和挑战
      • 安全和隐私问题
      • 缺乏熟练的 IT 专业人员
  • 增长分析
    • 按组件
    • 通过申请
    • 按销售渠道
  • COVID-19 影响分析
  • 数位健康、数位医学和数位治疗之间的区别
  • 监管状况
    • 美国
    • 欧洲
  • 赎回场景
    • 美国
    • 欧洲
  • 投资概览
  • 技术趋势分析
  • 领先数位治疗公司的研发渠道
  • 按治疗领域划分的数位疗法用例和应用
  • 数位疗法对主要利益相关者的影响
  • 数位治疗 - 生物製药案例，2019 年版
  • 波特分析
  • PESTEL 分析

第 4 章竞争格局，2021 年

  • 介绍
  • 2021 年公司矩阵分析
  • 战略仪表板，2021 年

第 5 章数位治疗市场：按组件分类

  • 主要细分趋势
  • 软件
  • 设备

第 6 章数位治疗市场：按应用

  • 主要细分趋势
  • 糖尿病
  • 肥胖
  • 心血管系统
  • 心理和行为健康
  • 高血压
  • 失眠
  • 其他

第 7 章数位治疗市场：按销售渠道

  • 主要细分趋势
  • 企业对企业 (B2B)
  • 企业对消费者 (B2C)

第 8 章数位治疗市场：按地区

  • 主要区域趋势
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 新加坡
  • 拉丁美洲
    • 墨西哥
    • 巴西
  • 多边环境协定
    • 沙特阿拉伯
    • 南非
    • 以色列

第九章公司简介

  • Otsuka Holdings Co., Ltd.
  • Propeller Health（ResMed）
  • Virta Health Corp
  • Teladoc Health
  • Pear Therapeutics Inc
  • Omada Health Inc
  • Akili Interactive Labs
  • WellDoc, Inc.
  • Click Therapeutics
  • Biofourmis, Inc.
  • Lark Health
  • LifeScan, Inc.
  • DarioHealth
  • Voluntis
  • My Sugr（Roche）
Product Code: 5408

Global Digital Therapeutics Market is slated to expand steadily through 2032 owing to the surging adoption of digital therapeutics in the healthcare sector and its potential to deliver better quality of care.

Additionally, the market revenue is anticipated to increase significantly as digital therapeutics solutions have become a vital part of healthcare delivery. The expansion is also being aided by technological advancements, significant corporate investments in research, and worldwide government campaigns encouraging chronic disease treatment.

For instance, Teladoc Health launched Chronic Care Complete, a chronic condition management system, in February 2022. By utilizing connected health monitoring systems and offering a wide selection of treatment programs, the system expands access to health coaches, doctors, and mental health professionals. The strategic launch also enables the corporation to move ahead in its competition, thus increasing its revenue.

The digital therapeutics market has been divided in terms of component, application, sales channel, and region.

With respect to component, the device segment is speculated to gain substantial market share through the forecast period. Due to their critical function in managing chronic illnesses, digital therapeutic devices have grown in acceptance, which is primarily responsible for this noteworthy segmental expansion. The digital automated blood glucose meters display blood glucose readings that are within or outside the range, immediately. With the Bluetooth-ready, sync mobile app and tiny, slim design, customers can make smarter decisions about their health and have access to new possibilities for prevention.

Based on application, the mental & behavioral health segment is anticipated to grow at more than 34% CAGR from 2023 to 2032. The rapid growth is credited to the large patient population with mental illnesses and significant R&D spending on behavioral and mental health treatments. The demand for mental health solutions has been prompted by significant unmet medical requirements and the stress caused by pandemic mitigation steps.

From the regional front, the Europe digital therapeutics market is expected to proliferate robustly over the review timeline. The market potential in this area is being driven by factors such as growing accessibility to digital therapeutics, the development of a personalized regulatory framework to accommodate cutting-edge modalities such as DTx, supportive government initiatives, rising utilization, and an influx of angel investors funding tech startups in the digital therapeutics space.

The competitive landscape of the digital therapeutics market is considerably established. Some of the major competitors operating in the industry include Virta Health Corp., Omada Health, Akili Interactive Labs, Biofourmis, Inc., Lark Health, and more.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definitions
  • 1.2 Base estimates & working
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Digital therapeutics industry 360 degree synopsis, 2018-2032
  • 2.2 Business trends
    • 2.2.1 Component trends
    • 2.2.2 Application trends
    • 2.2.3 Sales channel trends
    • 2.2.4 Regional trends

Chapter 3 Digital Therapeutics Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2018-2032 (USD Million)
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing prevalence of chronic diseases
      • 3.3.1.2 Rising need for cost containment
      • 3.3.1.3 Potential to increase quality of care delivery
      • 3.3.1.4 Growing popularity of digital therapeutics
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Security and privacy issues
      • 3.3.2.2 Lack of skilled IT professionals
  • 3.4 Growth potential analysis
    • 3.4.1 By component
    • 3.4.2 By application
    • 3.4.3 By sales channel
  • 3.5 COVID-19 impact analysis
  • 3.6 Differences between digital health, digital medicine and digital therapeutics
  • 3.7 Regulatory landscape
    • 3.7.1 U.S.
    • 3.7.2 Europe
  • 3.8 Reimbursement scenario
    • 3.8.1 U.S.
    • 3.8.2 Europe
  • 3.9 Investment overview
  • 3.10 Technology trend analysis
  • 3.11 R&D pipeline for leading digital therapeutics companies
  • 3.12 Digital therapeutics use cases per therapeutic area and example applications
  • 3.13 Impact of digital therapeutics on key stakeholders
  • 3.14 Digital Therapeutics-Biopharma deals, 2019
  • 3.15 Porter's analysis
  • 3.16 PESTEL analysis

Chapter 4 Competitive Landscape, 2021

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2021
  • 4.3 Strategy dashboard, 2021

Chapter 5 Digital Therapeutics Market, By Component

  • 5.1 Key segment trends
  • 5.2 Software
    • 5.2.1 Market size, by region, 2018-2032 (USD Million)
  • 5.3 Device
    • 5.3.1 Market size ,by region, 2018-2032 (USD Million)

Chapter 6 Digital Therapeutics Market, By Application

  • 6.1 Key segment trends
  • 6.2 Diabetes
    • 6.2.1 Market size, by region, 2018-2032 (USD Million)
  • 6.3 Obesity
    • 6.3.1 Market size, by region, 2018-2032 (USD Million)
  • 6.4 Cardiovascular
    • 6.4.1 Market size, by region, 2018-2032 (USD Million)
  • 6.5 Mental & behavioral health
    • 6.5.1 Market size, by region, 2018-2032 (USD Million)
  • 6.6 Hypertension
    • 6.6.1 Market size, by region, 2018-2032 (USD Million)
  • 6.7 Insomnia
    • 6.7.1 Market size, by region, 2018-2032 (USD Million)
  • 6.8 Others
    • 6.8.1 Market size, by region, 2018-2032 (USD Million)

Chapter 7 Digital Therapeutics Market, By Sales channel

  • 7.1 Key segment trends
  • 7.2 Business-to-business (B2B)
    • 7.2.1 Market size, by region, 2018-2032 (USD Million)
  • 7.3 Business-to-consumers (B2C)
    • 7.3.1 Market size, by region, 2018-2032 (USD Million)

Chapter 8 Digital Therapeutics Market, By Region

  • 8.1 Key regional trends
  • 8.2 North America
    • 8.2.1 Market size, by country, 2018-2032 (USD Million)
    • 8.2.2 Market size, by component, 2018-2032 (USD Million)
    • 8.2.3 Market size, by application, 2018-2032 (USD Million)
    • 8.2.4 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.2.5 U.S.
      • 8.2.5.1 Market size, by component, 2018-2032 (USD Million)
      • 8.2.5.2 Market size, by application, 2018-2032 (USD Million)
      • 8.2.5.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.2.6 Canada
      • 8.2.6.1 Market size, by component, 2018-2032 (USD Million)
      • 8.2.6.2 Market size, by application, 2018-2032 (USD Million)
      • 8.2.6.3 Market size, by sales channel, 2018-2032 (USD Million)
  • 8.3 Europe
    • 8.3.1 Market size, by country, 2018-2032 (USD Million)
    • 8.3.2 Market size, by component, 2018-2032 (USD Million)
    • 8.3.3 Market size, by application, 2018-2032 (USD Million)
    • 8.3.4 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.3.5 Germany
      • 8.3.5.1 Market size, by component, 2018-2032 (USD Million)
      • 8.3.5.2 Market size, by application, 2018-2032 (USD Million)
      • 8.3.5.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.3.6 UK
      • 8.3.6.1 Market size, by component, 2018-2032 (USD Million)
      • 8.3.6.2 Market size, by application, 2018-2032 (USD Million)
      • 8.3.6.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.3.7 France
      • 8.3.7.1 Market size, by component, 2018-2032 (USD Million)
      • 8.3.7.2 Market size, by application, 2018-2032 (USD Million)
      • 8.3.7.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.3.8 Italy
      • 8.3.8.1 Market size, by component, 2018-2032 (USD Million)
      • 8.3.8.2 Market size, by application, 2018-2032 (USD Million)
      • 8.3.8.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.3.9 Spain
      • 8.3.9.1 Market size, by component, 2018-2032 (USD Million)
      • 8.3.9.2 Market size, by application, 2018-2032 (USD Million)
      • 8.3.9.3 Market size, by sales channel, 2018-2032 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Market size, by country, 2018-2032 (USD Million)
    • 8.4.2 Market size, by component, 2018-2032 (USD Million)
    • 8.4.3 Market size, by application, 2018-2032 (USD Million)
    • 8.4.4 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.4.5 Japan
      • 8.4.5.1 Market size, by component, 2018-2032 (USD Million)
      • 8.4.5.2 Market size, by application, 2018-2032 (USD Million)
      • 8.4.5.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.4.6 China
      • 8.4.6.1 Market size, by component, 2018-2032 (USD Million)
      • 8.4.6.2 Market size, by application, 2018-2032 (USD Million)
      • 8.4.6.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.4.7 India
      • 8.4.7.1 Market size, by component, 2018-2032 (USD Million)
      • 8.4.7.2 Market size, by application, 2018-2032 (USD Million)
      • 8.4.7.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.4.8 Australia
      • 8.4.8.1 Market size, by component, 2018-2032 (USD Million)
      • 8.4.8.2 Market size, by application, 2018-2032 (USD Million)
      • 8.4.8.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.4.9 Singapore
      • 8.4.9.1 Market size, by component, 2018-2032 (USD Million)
      • 8.4.9.2 Market size, by application, 2018-2032 (USD Million)
      • 8.4.9.3 Market size, by sales channel, 2018-2032 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Market size, by country, 2018-2032 (USD Million)
    • 8.5.2 Market size, by component, 2018-2032 (USD Million)
    • 8.5.3 Market size, by application, 2018-2032 (USD Million)
    • 8.5.4 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.5.5 Mexico
      • 8.5.5.1 Market size, by component, 2018-2032 (USD Million)
      • 8.5.5.2 Market size, by application, 2018-2032 (USD Million)
      • 8.5.5.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.5.6 Brazil
      • 8.5.6.1 Market size, by component, 2018-2032 (USD Million)
      • 8.5.6.2 Market size, by application, 2018-2032 (USD Million)
      • 8.5.6.3 Market size, by sales channel, 2018-2032 (USD Million)
  • 8.6 MEA
    • 8.6.1 Market size, by country, 2018-2032 (USD Million)
    • 8.6.2 Market size, by component, 2018-2032 (USD Million)
    • 8.6.3 Market size, by application, 2018-2032 (USD Million)
    • 8.6.4 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.6.5 Saudi Arabia
      • 8.6.5.1 Market size, by component, 2018-2032 (USD Million)
      • 8.6.5.2 Market size, by application, 2018-2032 (USD Million)
      • 8.6.5.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.6.6 South Africa
      • 8.6.6.1 Market size, by component, 2018-2032 (USD Million)
      • 8.6.6.2 Market size, by application, 2018-2032 (USD Million)
      • 8.6.6.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.6.7 Israel
      • 8.6.7.1 Market size, by component, 2018-2032 (USD Million)
      • 8.6.7.2 Market size, by application, 2018-2032 (USD Million)
      • 8.6.7.3 Market size, by sales channel, 2018-2032 (USD Million)

Chapter 9 Company Profiles

  • 9.1 Otsuka Holdings Co., Ltd.
    • 9.1.1 Business overview
    • 9.1.2 Financial data
    • 9.1.3 Product landscape
    • 9.1.4 Strategic outlook
    • 9.1.5 SWOT analysis
  • 9.2 Propeller Health (ResMed)
    • 9.2.1 Business overview
    • 9.2.2 Financial data
    • 9.2.3 Product landscape
    • 9.2.4 Strategic outlook
    • 9.2.5 SWOT analysis
  • 9.3 Virta Health Corp
    • 9.3.1 Business overview
    • 9.3.2 Financial data
    • 9.3.3 Product landscape
    • 9.3.4 Strategic outlook
    • 9.3.5 SWOT analysis
  • 9.4 Teladoc Health
    • 9.4.1 Business overview
    • 9.4.2 Financial data
    • 9.4.3 Product landscape
    • 9.4.4 Strategic outlook
    • 9.4.5 SWOT analysis
  • 9.5 Pear Therapeutics Inc
    • 9.5.1 Business overview
    • 9.5.2 Financial data
    • 9.5.3 Product landscape
    • 9.5.4 Strategic outlook
    • 9.5.5 SWOT analysis
  • 9.6 Omada Health Inc
    • 9.6.1 Business overview
    • 9.6.2 Financial data
    • 9.6.3 Product landscape
    • 9.6.4 Strategic outlook
    • 9.6.5 SWOT analysis
  • 9.7 Akili Interactive Labs
    • 9.7.1 Business overview
    • 9.7.2 Financial data
    • 9.7.3 Product landscape
    • 9.7.4 Strategic outlook
    • 9.7.5 SWOT analysis
  • 9.8 WellDoc, Inc.
    • 9.8.1 Business overview
    • 9.8.2 Financial data
    • 9.8.3 Product landscape
    • 9.8.4 Strategic outlook
    • 9.8.5 SWOT analysis
  • 9.9 Click Therapeutics
    • 9.9.1 Business overview
    • 9.9.2 Financial data
    • 9.9.3 Product landscape
    • 9.9.4 Strategic outlook
    • 9.9.5 SWOT analysis
  • 9.10 Biofourmis, Inc.
    • 9.10.1 Business overview
    • 9.10.2 Financial data
    • 9.10.3 Product landscape
    • 9.10.4 Strategic outlook
    • 9.10.5 SWOT analysis
  • 9.11 Lark Health
    • 9.11.1 Business overview
    • 9.11.2 Financial data
    • 9.11.3 Product landscape
    • 9.11.4 Strategic outlook
    • 9.11.5 SWOT analysis
  • 9.12 LifeScan, Inc.
    • 9.12.1 Business overview
    • 9.12.2 Financial data
    • 9.12.3 Product landscape
    • 9.12.4 Strategic outlook
    • 9.12.5 SWOT analysis
  • 9.13 DarioHealth
    • 9.13.1 Business overview
    • 9.13.2 Financial data
    • 9.13.3 Product landscape
    • 9.13.4 Strategic outlook
    • 9.13.5 SWOT analysis
  • 9.14 Voluntis
    • 9.14.1 Business overview
    • 9.14.2 Financial data
    • 9.14.3 Product landscape
    • 9.14.4 Strategic outlook
    • 9.14.5 SWOT analysis
  • 9.15 My Sugr (Roche)
    • 9.15.1 Business overview
    • 9.15.2 Financial data
    • 9.15.3 Product landscape
    • 9.15.4 Strategic outlook
    • 9.15.5 SWOT analysis

Data Tables

  • TABLE 1. Global digital therapeutics market, 2018 - 2024 (USD Million)
  • TABLE 2. Global digital therapeutics market, 2025 - 2032 (USD Million)
  • TABLE 3. Global digital therapeutics market, by component, 2018 - 2024 (USD Million)
  • TABLE 4. Global digital therapeutics market, by component, 2025 - 2032 (USD Million)
  • TABLE 5. Global digital therapeutics market, by application, 2018 - 2024 (USD Million)
  • TABLE 6. Global digital therapeutics market, by application, 2025 - 2032 (USD Million)
  • TABLE 7. Global digital therapeutics market, by sales channels, 2018 - 2024 (USD Million)
  • TABLE 8. Global digital therapeutics market, by sales channels, 2025 - 2032 (USD Million)
  • TABLE 9. Global digital therapeutics market, by region, 2018 - 2024 (USD Million)
  • TABLE 10. Global digital therapeutics market, by region, 2025 - 2032 (USD Million)
  • TABLE 11. Industry impact forces
  • TABLE 12. Software market, by region, 2018 - 2024 (USD Million)
  • TABLE 13. Software market, by region, 2025 - 2032 (USD Million)
  • TABLE 14. Devices market, by region, 2018 - 2024 (USD Million)
  • TABLE 15. Devices market, by region, 2025 - 2032 (USD Million)
  • TABLE 16. Diabetes market, by region, 2018 - 2024 (USD Million)
  • TABLE 17. Diabetes market, by region, 2025 - 2032 (USD Million)
  • TABLE 18. Obesity market, by region, 2018 - 2024 (USD Million)
  • TABLE 19. Obesity market, by region, 2025 - 2032 (USD Million)
  • TABLE 20. Cardiovascular market, by region, 2018 - 2024 (USD Million)
  • TABLE 21. Cardiovascular market, by region, 2025 - 2032 (USD Million)
  • TABLE 22. Mental & behavioral health market, by region, 2018 - 2024 (USD Million)
  • TABLE 23. Mental & behavioral health market, by region, 2025 - 2032 (USD Million)
  • TABLE 24. Hypertension market, by region, 2018 - 2024 (USD Million)
  • TABLE 25. Hypertension market, by region, 2025 - 2032 (USD Million)
  • TABLE 26. Insomnia market, by region, 2018 - 2024 (USD Million)
  • TABLE 27. Insomnia market, by region, 2025 - 2032 (USD Million)
  • TABLE 28. Others market, by region, 2018 - 2024 (USD Million)
  • TABLE 29. Others market, by region, 2025 - 2032 (USD Million)
  • TABLE 30. Business-to-business (B2B) market, by region, 2018 - 2024 (USD Million)
  • TABLE 31. Business-to-business (B2B) market, by region, 2025 - 2032 (USD Million)
  • TABLE 32. Business-to-consumers (B2C) market, by region, 2018 - 2024 (USD Million)
  • TABLE 33. Business-to-consumers (B2C) market, by region, 2025 - 2032 (USD Million)
  • TABLE 34. North America digital therapeutics market, by country, 2018 - 2024, (USD Million)
  • TABLE 35. North America digital therapeutics market, by country, 2025 - 2032, (USD Million)
  • TABLE 36. North America digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 37. North America digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 38. North America digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 39. North America digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 40. North America digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 41. North America digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 42. U.S. digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 43. U.S. digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 44. U.S. digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 45. U.S. digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 46. U.S. digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 47. U.S. digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 48. Canada digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 49. Canada digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 50. Canada digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 51. Canada digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 52. Canada digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 53. Canada digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 54. Europe digital therapeutics market, by country, 2018 - 2024, (USD Million)
  • TABLE 55. Europe digital therapeutics market, by country, 2025 - 2032, (USD Million)
  • TABLE 56. Europe digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 57. Europe digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 58. Europe digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 59. Europe digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 60. Europe digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 61. Europe digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 62. Germany digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 63. Germany digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 64. Germany digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 65. Germany digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 66. Germany digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 67. Germany digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 68. UK digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 69. UK digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 70. UK digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 71. UK digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 72. UK digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 73. UK digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 74. France digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 75. France digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 76. France digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 77. France digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 78. France digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 79. France digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 80. Italy digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 81. Italy digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 82. Italy digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 83. Italy digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 84. Italy digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 85. Italy digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 86. Spain digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 87. Spain digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 88. Spain digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 89. Spain digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 90. Spain digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 91. Spain digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 92. Asia Pacific digital therapeutics market, by country, 2018 - 2024, (USD Million)
  • TABLE 93. Asia Pacific digital therapeutics market, by country, 2025 - 2032, (USD Million)
  • TABLE 94. Asia Pacific digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 95. Asia Pacific digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 96. Asia Pacific digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 97. Asia Pacific digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 98. Asia Pacific digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 99. Asia Pacific digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 100. Japan digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 101. Japan digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 102. Japan digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 103. Japan digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 104. Japan digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 105. Japan digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 106. China digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 107. China digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 108. China digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 109. China digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 110. China digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 111. China digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 112. India digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 113. India digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 114. India digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 115. India digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 116. India digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 117. India digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 118. Australia digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 119. Australia digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 120. Australia digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 121. Australia digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 122. Australia digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 123. Australia digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 124. Singapore digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 125. Singapore digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 126. Singapore digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 127. Singapore digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 128. Singapore digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 129. Singapore digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 130. Latin America digital therapeutics market, by country, 2018 - 2024, (USD Million)
  • TABLE 131. Latin America digital therapeutics market, by country, 2025 - 2032, (USD Million)
  • TABLE 132. Latin America digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 133. Latin America digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 134. Latin America digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 135. Latin America digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 136. Latin America digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 137. Latin America digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 138. Brazil digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 139. Brazil digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 140. Brazil digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 141. Brazil digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 142. Brazil digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 143. Brazil digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 144. Mexico digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 145. Mexico digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 146. Mexico digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 147. Mexico digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 148. Mexico digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 149. Mexico digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 150. MEA digital therapeutics market, by country, 2018 - 2024, (USD Million)
  • TABLE 151. MEA digital therapeutics market, by country, 2025 - 2032, (USD Million)
  • TABLE 152. MEA digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 153. MEA digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 154. MEA digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 155. MEA digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 156. MEA digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 157. MEA digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 158. Saudi Arabia digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 159. Saudi Arabia digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 160. Saudi Arabia digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 161. Saudi Arabia digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 162. Saudi Arabia digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 163. Saudi Arabia digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 164. South Africa digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 165. South Africa digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 166. South Africa digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 167. South Africa digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 168. South Africa digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 169. South Africa digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 170. Israel digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 171. Israel digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 172. Israel digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 173. Israel digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 174. Israel digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 175. Israel digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)

Charts & Figures

  • FIG. 1 Top-down approach
  • FIG. 2 Breakdown of primary participants
  • FIG. 3 Digital therapeutics industry 360 degree synopsis, 2018 - 2032
  • FIG. 4 Industry segmentation
  • FIG. 5 Industry landscape, 2018 - 2032 (USD Million)
  • FIG. 6 Growth potential analysis, by component
  • FIG. 7 Growth potential analysis, by application
  • FIG. 8 Growth potential analysis, by sales channels
  • FIG. 9 Impact of digital therapeutics on key stakeholders
  • FIG. 10 Porter's analysis
  • FIG. 11 PESTEL analysis
  • FIG. 12 Company matrix analysis, 2021
  • FIG. 13 Strategy dashboard, 2021
  • FIG. 14 Key segment trends, by component
  • FIG. 15 Key segment trends, by application
  • FIG. 16 Key segment trends, by sales channels
  • FIG. 17 Key regional trends